PSA result came back with 0.2 ng/ml - 3.5 year after RP
Comments
-
Sabhan
Sabhan
I am in exactly the same boat (PSA 4, G7/4+3, T2c N0 M0 G7) with BCR just under a year with sadly a failr quick PSADT so I am probably (far?) worse off than you.
It is really annoying, isn't it.
My onco was clear that it was BCR (would not give prognosis) and stuck me on HT and am due RT.
I would not hold off too long as 0.2 appears to be a threshold number - that being said your PSADT is slower than mine so maybe shorter intervales between tests to determine status to derisk?
Good luck,
C
0 -
update
update
PSA = 0.2 (07/13/18) - was 0.2 (6/20/18)
Had a consultation with RO today (7/25/18). RO surprised that I had a recurrence given negative margin, no cancer in nodes, cancer contained in prostate gland etc... say it happens to 9% of the patients.
unlike URO (who ecommends RT only), RO recommends combined approach (RT and HT) to maximize cure before PSA hits 0.5. Protocol: 2 Lupron injections (3 months apart) and concurrently RT (7.5 weeks).
I was worried about short and specially long term side effects. The big question is wait a bit say 2-3 months to check PSA or dive into treatment next couple of weeks.
Appreciate your comments.
0 -
Numbersabhen said:update
update
PSA = 0.2 (07/13/18) - was 0.2 (6/20/18)
Had a consultation with RO today (7/25/18). RO surprised that I had a recurrence given negative margin, no cancer in nodes, cancer contained in prostate gland etc... say it happens to 9% of the patients.
unlike URO (who ecommends RT only), RO recommends combined approach (RT and HT) to maximize cure before PSA hits 0.5. Protocol: 2 Lupron injections (3 months apart) and concurrently RT (7.5 weeks).
I was worried about short and specially long term side effects. The big question is wait a bit say 2-3 months to check PSA or dive into treatment next couple of weeks.
Appreciate your comments.
Sabhen,
It is interesting that the R.O. said that metastasis occures in 9% of cases post-RP, when there was NO EVIDENCE of escape from the gland in the post-surgical reporting.
I was speaking to my own surgeon about 1.5 years after my own RP, and asked about potential for relapse. He said that there was a 90% or better liklihood that I would never see PCa again. Because I have not seen much data on such cases, I appreciate the R.O.'s comments.
max
0 -
Got my first shot of 3-month Lupron
I got my first shot this week to be followed by another one in 3-months. After one day. it looks as a non-event. It seems it takes a couple of week before the impact becomes noticeable. Plan to start RT around mid-august for a duration of about 8 weeks.
Cushions,
Good luck to you as well.
Sab
0 -
My similar experience just for reference
Sab,
This last PSA result signifies that your cancer is hormone dependent. Lupron has driven your circulating testosterone into castration levels (< 25 ng/dL) depriving the bandit from having it so that the bugger gone into submission. ADT works by turning the cancer indolent but the bandit never dies. It continues living using other means for survival such as feeding on the androgens from the adrenal gland (approximately 5% of total in circulation) or even from low levels of the powerful dihydrotestosterone which is refined from the low volume of any androgen still in circulation. Surely a fewer number of low aggressive cells die in the process.One should note that our body needs androgens to function so that we cannot eliminate them (or the sources producing it) all for good.
ADT is palliative. Radiation (RT) in the combo is the killing weapon. This is the blow we all aspire to occur from a treatment. Delaying RT can be done but in this battle of palliative weaponry the bandit becomes the winner for giving it the opportunity to adapt to the newer environment of low testosterone. These buggers manage to modify their androgen receptors and in time cause refractory by starting to produce androgens by themselves. This is human's natural means of adaptation and survival as explained in Darwin's theory. Our cells, benign and cancerous, got the switches require to survive if given a chance.
I know of guys that did ADT as solo prime treatment controlling the advancement of the cancer for over ten years. I myself am in IADT (intermittent approach) since 2010 after failed SRT. However each case is different and nobody knows how things turn out if not by experience.
Statistics say that salvage radiation in RP recurrences work better at unmasked PSA levels not much higher than 0.4 ng/ml. But the best results can only be expected from cases where the radiation planned field includes the whole cancer, which assurances at present days with available tools seems to be an impossible mission. SRT is typically done on guessing based on past experiences (higher number of successful cases). One needs luck in the process.
I have followed similar steps to yours at RP recurrence in 2001. Salvage radiation was also at the time the recommended standard but there were no fixed PSA thresholds set to trigger treatment. Radiating in the dark was not in my mind at all and therapies based on assumptions did not satisfy me. I researched and did all I could to locate the hidden bandit. ProstaScint and PET were the best options but these in those days used isotopes not totally specific to detect PCa. A famous oncologist recommended me for WW (AS in those times) allowing time for the cancer to develop further and become bigger to try detection in a scan. I did all sorts of exams every year till 2006 without a successful detection. The results were all false negatives to the exception of the PSA that grow from 0.42 to 3.60 along the 5 years. Salvage radiation was also done solo (ADT was not yet recommended in combies). Recurrence was diagnosed again in 2010 when I started the present IADT.
I had the ball in my hands back in 2001. You got it now. Time to roll it in your favor.
Best,
VGama
0 -
new PSA test <0.1 (Sept 5, 2018) after 1 month on Lupron</b>VascodaGama said:My similar experience just for reference
Sab,
This last PSA result signifies that your cancer is hormone dependent. Lupron has driven your circulating testosterone into castration levels (< 25 ng/dL) depriving the bandit from having it so that the bugger gone into submission. ADT works by turning the cancer indolent but the bandit never dies. It continues living using other means for survival such as feeding on the androgens from the adrenal gland (approximately 5% of total in circulation) or even from low levels of the powerful dihydrotestosterone which is refined from the low volume of any androgen still in circulation. Surely a fewer number of low aggressive cells die in the process.One should note that our body needs androgens to function so that we cannot eliminate them (or the sources producing it) all for good.
ADT is palliative. Radiation (RT) in the combo is the killing weapon. This is the blow we all aspire to occur from a treatment. Delaying RT can be done but in this battle of palliative weaponry the bandit becomes the winner for giving it the opportunity to adapt to the newer environment of low testosterone. These buggers manage to modify their androgen receptors and in time cause refractory by starting to produce androgens by themselves. This is human's natural means of adaptation and survival as explained in Darwin's theory. Our cells, benign and cancerous, got the switches require to survive if given a chance.
I know of guys that did ADT as solo prime treatment controlling the advancement of the cancer for over ten years. I myself am in IADT (intermittent approach) since 2010 after failed SRT. However each case is different and nobody knows how things turn out if not by experience.
Statistics say that salvage radiation in RP recurrences work better at unmasked PSA levels not much higher than 0.4 ng/ml. But the best results can only be expected from cases where the radiation planned field includes the whole cancer, which assurances at present days with available tools seems to be an impossible mission. SRT is typically done on guessing based on past experiences (higher number of successful cases). One needs luck in the process.
I have followed similar steps to yours at RP recurrence in 2001. Salvage radiation was also at the time the recommended standard but there were no fixed PSA thresholds set to trigger treatment. Radiating in the dark was not in my mind at all and therapies based on assumptions did not satisfy me. I researched and did all I could to locate the hidden bandit. ProstaScint and PET were the best options but these in those days used isotopes not totally specific to detect PCa. A famous oncologist recommended me for WW (AS in those times) allowing time for the cancer to develop further and become bigger to try detection in a scan. I did all sorts of exams every year till 2006 without a successful detection. The results were all false negatives to the exception of the PSA that grow from 0.42 to 3.60 along the 5 years. Salvage radiation was also done solo (ADT was not yet recommended in combies). Recurrence was diagnosed again in 2010 when I started the present IADT.
I had the ball in my hands back in 2001. You got it now. Time to roll it in your favor.
Best,
VGama
Thanks, VGama for sharing your personal experience. My goal is to aim for a cure. A combo looks like the best option after BCR. By the way, I did not experience any significant side effects from Lupron as I was expecting. My health insurance is up for renewal in October. I can upgrade to a different plan that has a lower cost deductible. I want to have SRT started about mid-October after the new plan. I will consider that still not too late...
Sab
Best0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.9K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 398 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 794 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 63 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 540 Sarcoma
- 734 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards